Clinical Trials Directory

Trials / Conditions / Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

7 registered clinical trials studyying Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingRisk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Stud
NCT04900623
Jonathan Schoenfeld, MD, MPHPhase 2
WithdrawnDigital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer
NCT04140513
Ohio State University Comprehensive Cancer CenterN/A
CompletedStudy of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unkn
NCT04489212
Mayo ClinicN/A
Active Not RecruitingDe-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patien
NCT03952585
National Cancer Institute (NCI)Phase 2 / Phase 3
Active Not RecruitingIpilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squ
NCT03799445
M.D. Anderson Cancer CenterPhase 2
TerminatedStereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Par
NCT03618134
Jonsson Comprehensive Cancer CenterPhase 1 / Phase 2
RecruitingBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With
NCT03010150
M.D. Anderson Cancer Center—